MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $0 | – | 38 | 0.0% | 0.00% | – |
Q1 2024 | $0 | – | 38 | 0.0% | 0.00% | – |
Q4 2023 | $0 | – | 38 | -50.0% | 0.00% | – |
Q3 2023 | $0 | – | 76 | +100.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 38 | -100.0% | 0.00% | – |
Q1 2023 | $134 | +7.2% | 190,007 | +14.0% | 0.00% | – |
Q4 2022 | $125 | -99.6% | 166,641 | +322.2% | 0.00% | – |
Q3 2022 | $34,000 | +54.5% | 39,470 | +97.4% | 0.00% | – |
Q2 2022 | $22,000 | -95.4% | 20,000 | -95.3% | 0.00% | – |
Q1 2022 | $477,000 | -60.0% | 426,085 | -42.9% | 0.00% | – |
Q4 2021 | $1,192,000 | +2383.3% | 745,588 | +3627.9% | 0.00% | – |
Q3 2021 | $48,000 | -23.8% | 20,000 | 0.0% | 0.00% | – |
Q2 2021 | $63,000 | -76.3% | 20,000 | -74.7% | 0.00% | – |
Q1 2021 | $266,000 | – | 78,988 | +987250.0% | 0.00% | – |
Q2 2019 | $0 | – | 8 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 2,435,806 | $1,721,871 | 0.88% |
Monaco Asset Management SAM | 1,316,245 | $930,454 | 0.28% |
DAFNA Capital Management LLC | 1,096,513 | $775,125 | 0.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,205,921 | 0.22% |
Clearline Capital LP | 2,052,709 | $1,451,060 | 0.22% |
Rubric Capital Management LP | 10,366,120 | $7,327,810 | 0.19% |
Orbimed Advisors | 7,747,891 | $5,476,984 | 0.11% |
Rock Springs Capital Management LP | 6,244,897 | $4,414,518 | 0.10% |
683 Capital Management, LLC | 2,000,000 | $1,413,801 | 0.10% |
Privium Fund Management (UK) Ltd | 177,200 | $131,128 | 0.10% |